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Abstract
Objective: To examine the effect on cardiovascular (CVD) risk factors of interventions 
to alter consultations between practitioners and patients with type 2 diabetes.
Search Strategy: Electronic and manual citation searching to identify relevant rand-
omized controlled trials (RCTs).
Inclusion Criteria: RCTs that compared usual care to interventions to alter consulta-
tions between practitioners and patients. The population was adults aged over 
18 years with type 2 diabetes. Trials were set in primary care.
Data extraction and synthesis: We recorded if explicit theory- based interventions were 
used, how consultations were measured to determine whether interventions had an ef-
fect on these and calculated weighted mean differences for CVD risk factors including 
glycated haemoglobin (HbA1c), systolic blood pressure (SBP), diastolic blood pressure 
(DBP), total cholesterol (TC), LDL cholesterol (LDL- C) and HDL cholesterol (HDL- C).
Results: We included seven RCTs with a total of 2277 patients with type 2 diabetes. A 
range of measures of the consultation was reported, and underlying theory to explain 
intervention processes was generally undeveloped and poorly applied. There were no 
overall effects on CVD risk factors; however, trials were heterogeneous. Subgroup 
analysis suggested some benefit among studies in which interventions demonstrated 
impact on consultations; statistically significant reductions in HbA1c levels (weighted 
mean	difference,	−0.53%;	95%	CI:	[−0.77,	−0.28];	P<.0001; I2=46%).
Conclusions: Evidence of effect on CVD risk factors from interventions to alter con-
sultations between practitioners and patients with type 2 diabetes was heterogeneous 
and inconclusive. This could be explained by variable impact of interventions on con-
sultations. More research is required that includes robust measures of the consulta-
tions and better development of theory to elucidate mechanisms.
K E Y W O R D S
cardiovascular disease, consultation, doctor-patient relationship, patient-practitioner 
interactions, type 2 diabetes
2  |     ﻿DAMBD﻿- AMIILER Let DIl
1  | INTRODUCTION
The processes by which patients and their practitioners interact during 
consultations are a potentially important modifiable context for opti-
mizing the delivery of health care. National Health Service (NHS) policy, 
national guidelines and medical training emphasize the value of consul-
tations in improving health- care quality and outcomes.1,2 Observational 
studies suggest a potential therapeutic effect of consultations in type 
2 diabetes; better patient- reported experiences of consultations have 
been associated with lower cardiovascular (CVD) risk factors, including 
glycosylated haemoglobin (HbA1c), blood pressure and lipids.
3-8 While 
the observational evidence is consistent, evidence from trials of inter-
ventions to alter consultations remains inconclusive. This may be due to 
variations in context, potential confounding variables in observational 
studies or reverse causality. Alternatively, this may be due to  suboptimal 
intervention development or delivery such that impact on consultations 
is limited. The many sources of heterogeneity identified in previous 
reviews among patient groups, intervention definition, health- care con-
text or outcomes may also contribute to inconsistency in trial findings. 
This heterogeneity has not previously been thoroughly examined and 
explained, thus limiting scientific value and clinical application.8,9
A review by our group in 2004 drew attention to these difficul-
ties and also to other methodological limitations including the lack of 
description of mechanisms or measurement of variables to test these.8 
However, our previous review like others combined primary and 
secondary care and merged multiple chronic diseases.8-10 Only one 
previous review has examined randomized controlled trials (RCTs) of 
interventions to alter consultations between patient and practitioners, 
specifically among people with type 2 diabetes. This was published 
over 10 years ago, did not include a meta- analysis and was not set 
in primary care.5 The findings from these previous reviews are there-
fore not directly generalizable to diabetes patients in primary care 
today, where the vast majority of type 2 diabetes is now managed in 
the UK. Since our last review, additional RCTs have been conducted. 
Accordingly, we undertook a systemic review and meta- analysis of 
RCTs specifically set in primary care and including patients with type 2 
diabetes. The primary aim was a quantitative synthesis of the literature 
to examine the effect of interventions to alter consultations between 
practitioners and patients with type 2 diabetes on CVD risk factors 
including glycosylated haemoglobin(HbA1c), systolic blood pres-
sure(SBP), diastolic blood pressure(DBP), total cholesterol (TC), LDL 
cholesterol (LDL- C) and HDL cholesterol (HDL- C). We also examined 
heterogeneity and explored potential sources to explain this.
2  | METHODS
2.1 | Search strategy
We performed an electronic search of the Cochrane Central Register 
of Controlled Trials (CENTRAL), MEDLINE and EMBASE from incep-
tion to August 2014. Monthly automated electronic search updates 
were then set up and the results screened until June 2016. Manual 
searching was also conducted from the reference lists of included stud-
ies, previous reviews on similar topics and conference abstracts.8,9,11 
Search terms were identified from earlier reviews related to consulta-
tions between patient and practitioner (full search strategy available 
from the authors on request).12,13 We used both free text and MESH 
terms and did not apply language or publication restrictions.
2.2 | Selection criteria
We included RCTs that compared usual care to interventions to alter 
consultations between practitioners and patients. The population 
was adults aged over 18 years with type 2 diabetes. Trials were set 
in primary care, or in community clinics that were comparable to UK 
primary care. Interventions to alter consultations are diverse and we 
therefore used a theoretical framework based on the Stewart et al. 
model of the patient- centred consultation for the purposes of our 
review, as shown in Figure 1.8,12 This is the most highly cited definition 
of the consultation in UK primary care. We included interventions that 
targeted at least one component of the consultation according to this 
model.14 Included trials reported data on at least one of the following 
outcomes: HbA1c, SBP, DBP, total cholesterol, LDL- C or HDL- C levels.
2.3 | Process indicators
We examined descriptions of interventions and recorded if these 
were based on any explicit theoretical rationale or framework. We 
also recorded whether trials included any measures of the consulta-
tion to demonstrate an effect of the intervention on the consultation.
2.4 | Data extraction and validity assessment
One author (HDM) screened all titles, and a second author (AC) inde-
pendently	screened	10%	of	titles.	Both	authors	then	independently	
reviewed all included abstracts and full text papers for data extrac-
tion and methodological quality. Quality was appraised by examining 
each paper’s description and making a judgement regarding potential 
F I G U R E  1 Conceptual framework to 
define the consultation12
• Exploring both the disease and the illness experience 
• Understanding the whole person 
• Finding common ground regarding management 
• Incorporating prevention and health promotion 
• Enhancing the doctor-patient relationship 
• ‘Being realistic’ about personal limitations and issues such as the availability of time and 
resources
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bias using the criteria of randomization, sequence generation allo-
cation concealment, blinding, comparability of groups at baseline, 
incomplete data reporting and selective reporting.15 For each crite-
rion, we recorded potential risk of bias according to three catego-
ries: yes, no or risk unclear. Disagreements were documented and 
resolved by discussion. We also met with a third reviewer three 
times (SJG), and a fourth reviewer (ALK) was consulted on one occa-
sion as well. Our main discussions related to the fact that data were 
not	 always	 reported	as	mean	difference	and	95%	CIs.	There	were	
also some discussions about one trial that was not set in primary care 
and was instead based in a community outreach clinic. As a result of 
these discussions, we included a sensitivity analysis with and without 
this trial which is described below. We tested for evidence of publi-
cation bias with a standard funnel plot generated using the RevMan 
software.
2.5 | Data synthesis and analysis
We	 pooled	 weighted	 mean	 difference	 and	 95%	 CIs	 in	 a	 random-	
effects model that was then inserted into the RevMan software for 
statistical analysis.15,16 We also sought the advice of two statisticians 
during the data extraction phase. If trials reported on the outcome 
of interest but the data were not in a form that could permit meta- 
analysis, we requested additional data from authors. For example, 
trials reported the median with a range, instead of mean and stand-
ard deviation. Data were requested from five authors. Rather than 
omitting the trials from the meta- analysis if no author response was 
received, which could introduce bias and reduce statistical power, 
we used established imputation methods with the advice of statisti-
cians.14,17 Data reported from the same trial at different time points 
were included only once in the analysis. We used the I2 statistic to 
assess heterogeneity for each outcome. I2	 values	of	25%,	50%	and	
75%	 represented	 low,	 medium	 and	 high	 degrees	 of	 heterogeneity,	
respectively.15 Where high levels of heterogeneity were detected, 
we conducted subgroup analysis to understand the reasons for this 
heterogeneity including assessment of the following on the effect on 
CVD risk factors: (i) whether trials reported consultation measures 
that suggested the interventions had an effect on altering the con-
sultation, (ii) trial duration, (iii) whether the intervention targeted the 
patient, practitioner or both, (iv) whether the practitioners were doc-
tors, nurses, allied health professionals or a combination, (v) diabetes 
severity based on HbA1c level and (vi) whether trials were set outside 
of the UK. Further, we conducted a sensitivity analysis with the meta- 
analyses recalculated after excluding a trial that was not set in primary 
care but instead in a clinic that was comparable to UK primary care.
3  | RESULTS
We identified 6502 potentially relevant studies. Of these, 485 were 
removed electronically as they were either duplicates or clearly fell 
outside our inclusion criteria, and we screened the remainder by title. 
F IGURE  2 The flow of information 
through the systematic review
Records identified through database
searching
(n = 6499)
Additional records identified through other
sources
(n = 3)
Records screened by title after duplicates removed
(n = 6017)
Records screened by abstract
(n = 132)
Records excluded
(n = 117)
Full-text articles assessed for
eligibility
(n = 15)
Full-text articles excluded
(n = 8)
5 excluded due to setting in
secondary care [32–36]
2 excluded as more than one
report from the same trial [20,37]
1 excluded as intervention did not
alter patient-practitioner
interaction according to our
conceptual model [38]
Studies included in quantitative
synthesis (meta-analysis)
(n = 7)
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In the second round, 132 studies remained. Following screening of 
abstracts, we identified 15 studies for a third round of screening with 
full text assessment. Seven RCTs met the inclusion criteria. The flow of 
information through the systematic review is demonstrated in Figure 2.
3.1 | Study characteristics
The characteristics of the seven included RCTs are summarized in 
Table 1. Three trials were conducted in the USA, three in the UK and one 
in Denmark. The majority were set in primary care with the exception of 
one study, which was in a general internal medicine clinic.18 However, 
the trial adopted a chronic care model that is comparable to the UK pri-
mary care system, and after discussions between reviewers, we agreed 
to include it.19 Trial duration ranged from 12 months to 6 years, and the 
sample	 sizes	 ranged	 from	83	 to	875	participants	 of	which	47%-	77%	
were male. In total, this review included 2277 participants with varying 
levels of glycaemic control; mean baseline HbA1c values across studies 
ranged	from	6.8%	to	11.6%	in	the	six	trials	that	reported	this	informa-
tion. Participant characteristics are summarized in Table 2.
All RCTs targeted more than one aspect of the consultation 
according to our theoretical model as shown in Table 3. There were 
a total of eight interventions across the seven trials. Interventions 
were frequently complex behavioural interventions aimed at achiev-
ing behavioural change although we found that no specific frame-
works had been used to underpin the interventions or designs. Four 
of the included RCTs did not include any theoretical rationale to 
explain how interventions might have an effect on outcomes, and 
no trials directly related these to testing of potential underlying 
mechanisms.
Interventions to alter consultations were expectedly diverse, 
and most of these were not conducted within face- to- face con-
sultations between patients and practitioners. Instead of alter-
ing elements of the traditional face- to- face consultation model, 
interventions seemed to run parallel to these in order to augment 
the consultation. This was particularly observed in more recent 
trials that included type 2 diabetes patients working with case 
 managers,18 dieticians20 or diabetes educators,13 as well as group 
education sessions20 or sharing medical records with patients 
through web- based care.18 In the newer studies, we observed a 
greater move towards multidisciplinarity and multisystem redesign 
aiming to enable patients and empower them to alter the consulta-
tion with the practitioner.
Across trials, quality varied with the biggest source of bias related 
to allocation concealment; however, interventions cannot be fully 
concealed from practitioners and patients in these sorts of studies. A 
summary of risk of bias assessment is included. (Table 1)
3.2 | Process indicators
Only one trial included an independent objective measure of the 
consultation through the analysis of audio- recordings of consulta-
tions.21 Five trials included self- report measures of the consultation 
including provider feedback22; patient- completed questionnaires on F
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satisfaction, patient empowerment and patient diabetes knowledge20; 
and consultation communication scores.23 One trial observed the 
number of times that patients had accessed their medical records, 
uploaded information and communicated via email with practitioner.18 
Of the trials that had included any measures of the consultation, five 
reported a difference in at least one of the included measures sug-
gesting that the intervention may have had an effect on the consulta-
tion. (Table 4)
3.3 | Quantitative data synthesis
Overall, interventions to alter patient- practitioner interactions 
were not significantly associated with difference in HbA1c levels 
(weighted	mean	difference,	−0.22%;	95%	CI:	[−0.56,	0.12];	P=.21; 
I2=80%),	 SBP	 (weighted	mean	 difference,	 −1.87	mm	Hg;	 95%	CI:	
[−4.87,	 1.13];	 P=.22; I2=49%),	 DBP	 (weighted	 mean	 difference,	
0.03	mm	Hg;	95%	CI:	 [−1.44,	1.50]	P=.96;	 I2=39%),	TC	 (weighted	
mean	 difference,	 −0.03	mmol/L;	 95%	 CI:	 [−0.24,0.18]	 P=.81; 
I2=53%),	LDL-	C	(weighted	mean	difference,	0.20	mmol/L;	95%	CI:	
[−0.20,	0.60]	P=.33 I2=86%)	and	HDL-	C	(weighted	mean	difference,	
0.03	mmol/L;	95%	CI:	[−0.04,	0.09]	P=.41 I2=0%)	when	compared	
with usual care.
In subgroup analyses to explore heterogeneity, we found that 
interventions with measurable impact on the consultation were 
associated with reduced HbA1c levels (weighted mean difference, 
−0.53%;	 95%	 CI:	 [−0.77,	 −0.28];	 P<.0001; I2=46%)	 and	 a	 trend	
towards reduced blood pressure levels which did not reach statis-
tical	 significance:	 SBP	 (weighted	mean	difference,	 −2.53	mm	Hg;	
95%	CI:	 [−6.52,	 1.46];	P<.21; I2=67%)	 and	DBP	 (weighted	mean	
difference,	 −0.43	mm	Hg;	95%	CI:	 [−2.05,	 1.18];	P<.18; I2=42%).	
(Figure 3). Heterogeneity was reduced in this subgroup from high 
to moderate levels. None of the other remaining specified sub-
group analyses reduced heterogeneity according to the I2 statistic. 
There were too few trials reporting lipid levels for meaningful sub-
group analysis of these outcomes. Finally, we included one study 
that was not set in primary care although comparable to this set-
ting; removal of this study from the analysis made no difference to 
our findings.
3.4 | Publication bias
Funnel plots suggested a low likelihood of publication bias for out-
comes apart from lipid levels where there were too few studies to 
assess.
First author Age (years) Sex (% male)
Ethnicity (% 
non- white)
Baseline HbA1c 
(%)
Christian31 53 47 50 8.2
Deakin20 61 52 Not reported 7.7
De fine Olivarius22 65 52a Not reported 10.2a
Kinmonth23 57 62 Not reported Not reported
Piatt13 65 48 10 6.8
Pill21 58 64 Not reported 11.6
Ralston18 41 77 81 8.1
Age and HbA1c reported as means unless stated.
aIndicates data reported as medians.
TABLE  2 Characteristics of study 
participants
TABLE  3 Characteristics of the intervention according to the Stewart et al. consultation model 12
First author
Exploring both 
the disease and 
the illness 
experience
Understanding 
the whole 
person
Finding common 
ground regarding 
management
Incorporating 
prevention and 
health promotion
Enhancing the 
doctor- patient 
relationship
“Being realistic” about 
personal limitations and 
issues such as the availabil-
ity of time and resources
Christian31
Deakin20
De fine Olivarius22
Kinmonth23
Piatt A13
Piatt B13
Pill21
Ralston18
Piatt study had two different intervention arms and is therefore identified as “A” and “B”.
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4  | DISCUSSION
4.1 | Summary
To our knowledge, this is the first meta- analysis of RCTs examining 
the effect on CVD risk factors of interventions to alter consultations 
between primary care practitioners and patients with type 2 diabe-
tes. We identified seven studies including 2277 participants with 
type 2 diabetes. Overall, interventions to alter consultations were not 
 associated with improvements in CVD risk factors. However,  trials 
were heterogeneous and subgroup analyses highlight the poten-
tial for important benefit on glycaemic control of interventions that 
demonstrated impact on the consultation (reductions in HbA1c levels 
of	−0.53%	(5.7	mmol/mol)).	There	is	a	need	for	further	research	that	
includes consistent use of valid and reliable measures to demonstrate 
effect on consultations, alongside better development and incorpora-
tion of theory to elucidate mechanisms.
4.2 | Strengths and limitations
Main strengths are that we conducted a systematic search of the litera-
ture that included no language or publication restrictions. We searched 
the grey literature, included studies identified in previous reviews and 
conducted hand searching of the literature to capture all relevant trials. 
It is possible that further trials have been conducted since our literature 
search. However, our electronic search updates since this time do not 
suggest additional published trials that would meet the inclusion criteria 
of our review. Limitations include the fact that the term “consultation” 
is a broad and multifaceted concept with various naming conventions 
and theoretical models.3,12,24-26 It is possible, therefore, that our search 
strategy may not have identified all relevant trials. As our search identi-
fied over 6000 titles, we did not extend it to include social sciences 
and non- English language databases. However, the symmetrical funnel 
plot does not suggest that we have overlooked numerous negative tri-
als. Only one of five authors approached responded to our requests 
for further information. We therefore extracted data and interpreted 
these without reference to original authors which could have intro-
duced uncertainty in the meta- analysis.14 However, there is recent 
evidence in favour of imputation methods within systemic reviews as 
preferable to omitting trials which could have led to a greater level of 
inaccuracy.17 We conducted multiple exploratory subgroup analyses 
and cannot exclude the role of chance as a plausible explanation for 
our findings. In our subgroup analysis, we pooled together studies that 
were likely to have altered the consultation based on the inclusion and 
TABLE  4 Consultation measures to demonstrate evidence of impact of interventions on the consultation
Study: 1st author Measures of the consultation
Reported differences in these measures between the 
intervention and control groups
Christian31 None reported
Deakin20 No direct measure of the consultation but included patient- 
completed questionnaires about treatment satisfaction, 
diabetes empowerment scores and diabetes knowledge 
scores
Significant differences in treatment satisfaction, diabetes 
empowerment and diabetes knowledge between groups
Kinmonth23 No direct measure of the consultation but included patient- 
completed questionnaires with ratings of communication, 
satisfaction with treatment, style of care and knowledge of 
perceived control of diabetes
Intervention group report significantly higher communication 
scores with GPs, treatment satisfaction score and patient 
self- reported knowledge score. No other measures 
demonstrated significant change between groups
Piatt13 No reported measures of consultation but included self report 
questionnaires on diabetes empowerment scale and diabetes 
knowledge test score
No statistically significant differences between groups in 
empowerment scale and diabetes knowledge test scores
Pill21 Direct measure of consultation through audio- recordings. Also 
included qualitative feedback and questionnaire about 
understanding and implementation of intervention into 
practice from practitioners
Analysis of audio- recording suggested more topic discussed 
with patients in intervention than control group. Patient 
participation in relation to “affirming health behaviours and 
initiating discussions of change” were significantly better in 
intervention than control group
Ralston18 No direct measure of consultations but reviewed patient 
activation by assessing number of clinic appointments, 
number of emails exchanged with practitioner and number of 
times that participants looked at e- records and uploaded their 
blood glucose levels onto the web
Although no difference overall in the way health- care services 
were used between intervention and control group, there is 
some evidence of effect on consultation from self- report 
data. Care manager suggested an average of 4 hours per 
week updating care plans and communicating with patients 
over	the	web	in	the	intervention	group,	and	76%	of	
intervention group accessed their medical records
De fine Olivarius22 No direct measure of consultation but did include question-
naire on practitioners’ perceptions of participation, motivation 
and attitudes of their patients. Data also collected on 
differences in the way health- care services were used by 
patients in terms of diabetes annual and three- monthly 
review attendance and total number of consultations
Significant differences in practitioners’ perceptions of patient 
participation and motivation between groups. There were 
also significant differences in the attendance and number of 
consultations by patients between groups
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(i)
(ii)
(iii)
F IGURE  3 Forest plots of the effect of interventions to alter consultations between practitioners and type 2 diabetes patients, showing 
differences in outcomes of trials with and without demonstrable impact on the consultation. (i) Effect of interventions to alter consultations 
on HbA1c levels (ii) Effect of interventions to alter consultations on systolic blood pressure. (iii) Effect of interventions to alter consultations on 
diastolic blood pressure
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reporting of consultation measures. However, it is plausible that some 
of the studies that did not include any measures of the consultation 
may still have had an effect on the consultation. Finally, there are many 
different ways to alter the consultation and the interventions reflected 
this; consequently, between- study heterogeneity was high which is an 
argument against meta- analysis.
4.3 | Comparison with existing literature
A previous review, conducted over a decade ago, suggested that 
altering the consultation may have a clinically important effect on 
HbA1c levels and diabetes outcomes.
5 However, this was a descriptive 
review with no meta- analysis and it combined primary and second-
ary care settings. A more recent meta- analysis of the effect on health 
outcomes of interventions to alter the consultation again reported a 
similar clinically important effect that favoured interventions.9 This 
was conducted across multiple health conditions with only three tri-
als in the review that were related to type 2 diabetes. Our current 
meta- analysis builds on our earlier work and these reviews by includ-
ing additional and larger trials that are specific to type 2 diabetes and 
primary care.8
It has been 10 years since our last review, and some progress 
has been made; five additional trials have been published measuring 
health outcomes in type 2 diabetes, and some trials included mea-
sures of process. However, there is still work to be done; trials are 
not consistently including and reporting measures of the consulta-
tion to demonstrate that interventions actually alter consultations. 
While there are a multitude of recognized patient- centred consulta-
tion measures within the literature, none of these feature in included 
trials.25 Further, while there is now a better understanding of complex 
behavioural interventions in the literature and improved frameworks 
to guide the design and planning of interventions since our last review, 
none of these frameworks seem to have been used within included 
trials.27,28 This might be one explanation for the lack of overall effects 
observed in this and previous reviews.28,29 A previous report sug-
gested that the majority of systematic reviews involving complex 
behavioural intervention do not tend to report strong effects.30 
Reasons for this are suggested to be that complex behavioural inter-
ventions tend to be poorly described and developed which is what 
we found in our review.30 More theoretical work is needed to better 
understand the aspects of the consultation that could be amenable to 
change, how these may be related to health outcomes of interest and 
how to effectively change these within an intervention.
Finally, our findings could help to explain the discrepancy in the 
literature between trial and observational evidence on the potential 
effect of consultations on health outcomes among people with type 
2 diabetes.3-6 Our findings suggest variable impact of interventions 
on the consultation as an explanation for previous inconsistency. 
However, there are additional plausible explanations that should be 
considered to provide a complete view. These could include consulta-
tion context (eg varying health literacy, language or mental capacity), 
reverse causality, potential confounding variables in trials compared 
to observational evidence and the limitation of the RCT design itself 
which imposes a structure on the patient- practitioner interaction that 
is key to its control design.
5  | CONCLUSIONS
More health care in the UK is being delivered in primary care. There 
are increasing calls from policymakers and health professionals for more 
enabling consultations that address both disease and illness experience 
in patients with type 2 diabetes. However, the step from concept to 
operation remains challenging. This review provides some evidence of 
the potential of the consultation in primary care to improve CVD risk fac-
tors. But there is a need for more innovation in diabetes care for the 21st 
century in relation to the consultation between patient and practitioner. 
In this review, we observed that interventions to alter consultations have 
now moved beyond the traditional face- to- face consultation between 
practitioner and patient and towards system redesign to enable patient 
participation, empowerment and the inclusion of the primary care mul-
tidisciplinary team. This in turn could augment the direct consultation 
between practitioner and patient with type 2 diabetes. Consequently, 
future well- conducted RCTs that take context as well as relationship 
into account are needed. Trials should include better descriptions of 
interventions, theoretical frameworks to underpin the interventions and 
robust measures of consultations to confirm that key aspects of the con-
sultation and their context are being successfully enhanced.
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